Featured
Announcements
Advertisement
Trending - Altmetric
-
EZH2: biology, disease, and structure-based drug discovery
-
AI-driven antibody design with generative diffusion models: current insights and future directions
-
LN-439A, a novel BAP1 inhibitor, suppresses the growth of basal-like breast cancer by degrading KLF5
-
Structure of the PRC2 complex and application to drug discovery